Overview
Juha Klefstrom practices practicing medicine in Helsinki, Finland.
Klefstrom is highly rated in 1 condition, according to our data. Their clinical expertise encompasses Breast Cancer, Coenzyme Q Cytochrome C Reductase Deficiency, Triple-Negative Breast Cancer, and Head and Neck Squamous Cell Carcinoma (HNSCC).
They are actively involved in clinical research, co-authoring 44 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Juha Klefstrom
Is Juha Klefstrom a top-rated expert for Breast Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Juha Klefstrom is classified as an Advanced expert for Breast Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Juha Klefstrom participate in research or clinical trials?
Yes. Juha Klefstrom has published 44 articles and abstracts on conditions like Breast Cancer. You can view a list of Juha Klefstrom's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Breast CancerKlefstrom isAdvanced. Learn about Breast Cancer.
- Experienced
- Coenzyme Q Cytochrome C Reductase Deficiency
- Head and Neck Squamous Cell Carcinoma (HNSCC)
- Triple-Negative Breast CancerKlefstrom isExperienced. Learn about Triple-Negative Breast Cancer.